<DOC>
	<DOC>NCT01912092</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy of Askina速 Calgitrol速 Paste in reducing local infection in subjects treated for mildly infected Diabetic Foot Ulcers (DFU) with Askina速 Calgitrol速 Paste.</brief_summary>
	<brief_title>Askina Calgitrol Paste Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Subject older than 18 years old Provision of written consent by the subject themselves Subjects with a Texas stage IB wound below the malleolus: superficial and infected (WagnerArmstrong classification system). Subjects with a mildly infected wound according to the Infectious Diseases Society of America (IDSA). Size of wound &gt;2 cm2. Absence of ischaemia of the lower limb as assessed by : 1. Transcutaneous oxygen pressure (TcPO2) &gt; 30 mmHg. 2. Toe pressure &gt; 50 mmHg. 3. Ankle pressure &gt; 70 mmHg. Capable of following Study instructions. Compliant with treatment and in particular with offloading regime. Stable management of their diabetes as defined by an HbA1C (%) of 12% Subjects who are &lt;18 years old. Subjects with a documented sensitivity to alginates or silver. Subjects taking a medication or using a device comprising silver. Subjects already taking antibiotics before enrolment Subjects undergoing dialysis. Subjects using therapy known to be immunecompromising such as systemic antineoplastic drugs and/or systemic corticosteriods. Pregnancy Breastfeeding Currently participating in another clinical trial, or who have participated in another clinical trial in the last 6 weeks or who have previously taken part in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>